{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:14:28Z","timestamp":1762431268779},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Endometrial polyps are benign pathologies originating as localized overgrowths of basal endometrium. Risk factors include endogenous and exogenous estrogen excess and tamoxifen (TAM) exposure. Our main objective was to investigate the role of an apoptosis-inhibiting protein, survivin, in endometrial polyps. We performed a cross-sectional, analytical study; our samples were obtained from the archives of the Department of Pathology. Sixty samples were included, comprising 20 TAM polyps, 20 simple endometrial polyps, and 20 cases of simple endometrial hyperplasia without atypia not associated with TAM use. Immunohistochemical staining with rabbit monoclonal anti-human survivin, clone EP 119, was performed. Survivin staining score was highest in the endometrial polyp group and lowest in the TAM polyp group (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001). There was no correlation between survivin staining score and the age of patient (<jats:italic toggle=\"yes\">r<\/jats:italic>=0.09), TAM exposure (<jats:italic toggle=\"yes\">r<\/jats:italic>=\u22120.02), nor endometrial thickness (<jats:italic toggle=\"yes\">r<\/jats:italic>=0.25). Endometrial polyps are frequently associated with TAM. The low expression of the antiapoptotic marker survivin in TAM polyps but high expression in other polypoid endometrium illustrates that different mechanisms are responsible in the pathogenesis of endometrial polyps. It is possible that there is a direct effect of TAM on apoptosis or indirect effect through a progesterone-related mechanism.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000376","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T14:00:06Z","timestamp":1489845606000},"page":"27-31","source":"Crossref","is-referenced-by-count":6,"title":["Survivin Expression in Simple Endometrial Polyps and Tamoxifen-associated Endometrial Polyps"],"prefix":"10.1097","volume":"37","author":[{"given":"Ayse F.","family":"Gokmen Karasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma C.","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serdar","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilknur","family":"Adanir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Marasli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsah K.","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230824","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-199501000-00003","article-title":"Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving anti-estrogens (tamoxifen) and gestagens","volume":"14","author":"Dallenbach-Hellweg","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00004347-199810000-00003","article-title":"Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups","volume":"17","author":"Schlesinger","year":"1998","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ygyno.2004.03.048","article-title":"Endometrial pathologies associated with postmenopausal tamoxifen treatment","volume":"94","author":"Cohen","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R4-20230824","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"R5-20230824","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery","volume":"8","author":"Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"R6-20230824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4020-6554-5_4","article-title":"Apoptotic pathways in tumor progression and therapy","volume":"615","author":"Melet","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"R7-20230824","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/molehr\/6.6.529","article-title":"Expression of survivin and Bcl-2 in the normal human endometrium","volume":"6","author":"Konno","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/humupd\/1.4.303","article-title":"Signals and molecular pathways involved in apoptosis, with special emphasis on human endometrium","volume":"1","author":"Tabibzadeh","year":"1995","journal-title":"Hum Reprod Update"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0301-2115(96)02467-0","article-title":"Apoptosis: a programmed cell death involved in ovarian and uterine physiology","volume":"67","author":"Vinatier","year":"1996","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1096-9896(199611)180:3<275::AID-PATH660>3.0.CO;2-A","article-title":"Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinoma","volume":"180","author":"Seagusa","year":"1996","journal-title":"J Pathol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/gyno.2000.5803","article-title":"Differential expression of antiapoptotic genes in human endometrial carcinoma: bcl-xL succeeds bcl-2 function in neoplastic cells","volume":"77","author":"Crescenzi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/gyno.2000.5744","article-title":"Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: an approach using multiparameter flow cytometry","volume":"77","author":"Morsi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R13-20230824","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1471-0528.2003.02098.x","article-title":"The differential expression of ER, PR, Bcl-2 and Ki67 in endometrial polyps","volume":"110","author":"Taylor","year":"2003","journal-title":"Br J Obstet Gynaecol"},{"key":"R14-20230824","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004347-200204000-00008","article-title":"Dissociated expression of Bcl-2 and ki-67 in endometrial lesions: diagnostic and histogenetic implications","volume":"21","author":"Risberg","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R15-20230824","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.cdd.4400598","article-title":"Caspase structure, proteolytic substrates, and function during apoptotic cell death","volume":"6","author":"Nicholson","year":"1999","journal-title":"Cell Death Differ"},{"key":"R16-20230824","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/A:1007081021483","article-title":"Bcl-2, survivin and variant CD44 v7-v10 are downregulated and p53 is upregulated in breast cancer cells by progesterone: inhibition of cell growth and induction of apoptosis","volume":"202","author":"Formby","year":"1999","journal-title":"Mol Cell Biochem"},{"key":"R17-20230824","first-page":"524","article-title":"The progestin-like activity of tamoxifen on the endometrium","volume":"suppl 4","author":"Dallenbach-Hellweg","year":"1998","journal-title":"Eur J Cancer"},{"key":"R18-20230824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.maturitas.2005.11.007","article-title":"Does tamoxifen therapy affect the hormone receptor expression and cell proliferation indices of endometrial polyps? An immunohistochemical comparison of endometrial polyps from postmenopausal women exposed and not exposed to tamoxifen","volume":"54","author":"McGurgan","year":"2006","journal-title":"Maturitas"},{"key":"R19-20230824","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/modpathol.2009.25","article-title":"Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance","volume":"22","author":"Chen","year":"2009","journal-title":"Mod Pathol"},{"key":"R20-20230824","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/ijgc-00009577-200605000-00071","article-title":"Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium","volume":"16","author":"Erkanli","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"R21-20230824","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2006.03.007","article-title":"Structural, functional and therapeutic biology of survivin","volume":"244","author":"Sah","year":"2006","journal-title":"Cancer Lett"},{"key":"R22-20230824","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2009.02.005","article-title":"Endometrial hyperplasia and the risk of progression to carcinoma","volume":"63","author":"Lacey","year":"2009","journal-title":"Maturitas"},{"key":"R23-20230824","first-page":"443","article-title":"Tamoxifen activation of the estrogen receptor\/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens","volume":"9","author":"Webb","year":"1995","journal-title":"Mol Endocrinol"},{"key":"R24-20230824","first-page":"697","article-title":"Modulation of endometrial steroid receptors and grow regulatory genes by tamoxifen","volume":"95","author":"Elkas","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R25-20230824","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00280-004-0923-x","article-title":"Endometrial K-RAS mutations in postmenopausal breast cancer patients treated with adjuvant tamoxifen or toremifene","volume":"55","author":"Wall\u00e9n","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"R26-20230824","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.bjc.6600157","article-title":"Tamoxifen induction of angiogenic factor expression in endometrium","volume":"86","author":"Hague","year":"2002","journal-title":"Br J Cancer"},{"key":"R27-20230824","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00004347-198906000-00005","article-title":"Endometrial polyps in postmenopausal patients reviewing tamoxifen","volume":"8","author":"Nuovo","year":"1989","journal-title":"Int J Gynecol Pathol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00004347-201801000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:31:45Z","timestamp":1692840705000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004347-201801000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000376","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}